California Court Rules Against Bayer in Roundup Weedkiller Appeal
10 Agosto 2021 - 5:58AM
Noticias Dow Jones
By Matt Grossman
Bayer AG has lost an appeal of a California jury verdict that
tied the use of its Roundup weedkiller to cancer, a setback for the
German chemicals company as it plans to bring its defense of the
product to the U.S. Supreme Court.
On Monday, an appeals court in California upheld the jury's
verdict in a case brought by a husband and wife who both developed
non-Hodgkin lymphoma after years of using Roundup on their
property. The couple, Alberta and Alva Pilliod, had been awarded
about $86 million in damages.
The case is one of a handful in which state-court juries have
found that Roundup contributed to a user's cancer diagnosis. Bayer
inherited the Roundup weedkiller brand as part of its 2018
acquisition of Monsanto. The company says that the compound at
issue in the Roundup litigation, glyphosate, is safe, and it
continues to sell weedkiller that includes the chemical.
A spokeswoman for Bayer didn't immediately respond to an
inquiry.
Last month, Bayer said it is setting aside an additional $4.5
billion to cover expenses arising from Roundup litigation. Those
funds add to the $11.6 billion Bayer had previously said it could
pay.
Bayer has also said it will appeal a case similar to the
Pilliods' to the U.S. Supreme Court this month.
In part, Bayer has argued in the cases that state-court jury
verdicts should be preempted by federal law, because the federal
Environmental Protection Agency has said that glyphosate doesn't
pose a health risk.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
August 10, 2021 06:53 ET (10:53 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Bayer (TG:BAYN)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Bayer (TG:BAYN)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024